| |
| |
|
| Insider
Information: |
Ferreira Juan Camilo Arjona |
| Relationship: |
Officer |
| City: |
Brisbane |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
13 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$245 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
13 |
|
|
| Total
Value |
$245 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
16
|
|
Stock
price went up :
|
0
|
11
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.2
|
| Percentage
Gain/Loss : |
0.0%
|
 632.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Myovant Sciences Ltd. |
MYOV |
Chief Medical Officer |
2023-03-10 |
0 |
2017-08-15 |
0 |
Premium* |
|
|
Organon & Co. |
OGN |
Officer |
2024-01-01 |
13 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OGN |
Organon & Co. |
Head of R&D & CMOOfficer |
• – – |
2024-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
13 |
|
% |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2023-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(246,684) |
0 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2023-01-18 |
4 |
S |
$26.89 |
$29,821 |
D/D |
(1,109) |
246,684 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2023-01-04 |
4 |
S |
$26.90 |
$60,552 |
D/D |
(2,251) |
247,793 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2022-10-18 |
4 |
S |
$25.20 |
$40,421 |
D/D |
(1,604) |
250,044 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2022-10-04 |
4 |
S |
$24.40 |
$66,807 |
D/D |
(2,738) |
251,648 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2022-07-18 |
4 |
S |
$12.87 |
$20,669 |
D/D |
(1,606) |
254,386 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2022-07-06 |
4 |
S |
$13.40 |
$36,917 |
D/D |
(2,755) |
255,992 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2022-05-27 |
4 |
S |
$10.07 |
$13,917 |
D/D |
(1,382) |
258,747 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2022-04-19 |
4 |
S |
$10.45 |
$48,404 |
D/D |
(4,632) |
260,129 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2022-04-15 |
4 |
A |
$0.00 |
$0 |
D/D |
103,703 |
264,761 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2022-04-05 |
4 |
S |
$13.78 |
$26,485 |
D/D |
(1,922) |
161,058 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2022-03-01 |
4 |
S |
$13.35 |
$18,183 |
D/D |
(1,362) |
162,980 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2022-01-04 |
4 |
S |
$16.27 |
$36,949 |
D/D |
(2,271) |
164,342 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2021-11-04 |
4 |
AS |
$24.02 |
$74,462 |
D/D |
(3,100) |
168,591 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2021-11-04 |
4 |
OE |
$7.78 |
$24,118 |
D/D |
3,100 |
171,691 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2021-11-03 |
4 |
AS |
$24.00 |
$16,800 |
D/D |
(700) |
168,591 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2021-11-03 |
4 |
OE |
$7.78 |
$5,446 |
D/D |
700 |
169,291 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2021-10-05 |
4 |
S |
$21.62 |
$59,196 |
D/D |
(2,738) |
168,591 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2021-09-27 |
4 |
AS |
$24.32 |
$170,240 |
D/D |
(7,000) |
171,329 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2021-09-27 |
4 |
OE |
$7.78 |
$54,460 |
D/D |
7,000 |
178,329 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2021-08-30 |
4 |
AS |
$24.05 |
$505,050 |
D/D |
(21,000) |
171,329 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2021-08-30 |
4 |
OE |
$7.78 |
$163,380 |
D/D |
21,000 |
192,329 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2021-08-27 |
4 |
AS |
$22.69 |
$44,881 |
D/D |
(1,978) |
171,329 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2021-07-07 |
4 |
S |
$21.75 |
$60,400 |
D/D |
(2,777) |
173,307 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
